Position in LXRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$11,802,645
+$10,298,746 QoQ
Shares Held
4,917,769
+410.1% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. LXRX ranks #177 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in LXRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,802,645 | 4,917,769 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,503,899 | 964,038 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,017,448 | 884,738 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,188,163 | 880,121 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $777,689 | 818,621 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,199,484 | 2,607,574 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,011,503 | 2,718,248 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,879,807 | 2,471,215 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,886,641 | 2,313,477 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,770,024 | 1,987,510 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,895,248 | 1,892,319 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,044,991 | 1,876,139 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,961,956 | 1,730,112 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,800,758 | 1,564,098 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,896,467 | 1,516,475 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,512,565 | 1,463,569 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $2,514,721 | 1,352,001 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,767,964 | 1,324,385 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,787,170 | 1,215,018 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,299,431 | 1,101,753 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,762,799 | 1,037,647 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,404,759 | 750,385 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $2,491,791 | 728,594 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,079,798 | 749,860 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $1,491,876 | 745,938 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,612,293 | 826,817 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||